Recent Company News

• 06:52 AM ET Feb 19, 2026
  

  StreetAccount Summary - European unusual volume traders

• 06:02 AM ET Feb 05, 2026
  

  Transcript Intelligence: CellaVision Q4 Earnings Guidance

• 06:01 AM ET Feb 05, 2026
  

  Transcript Intelligence: CellaVision Q4 Earnings Themes

• 06:01 AM ET Feb 05, 2026
  

  Transcript Intelligence: CellaVision Q4 Earnings Q&A

• 04:38 AM ET Feb 05, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:25 AM ET Feb 05, 2026
  

  CellaVision reports Q4 EPS SEK1.79 vs FactSet SEK1.31 [4 est, SEK0.00-1.90] (SEK 141.00, 0.00)

• 04:00 AM ET Feb 04, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (208 total)

• 09:05 AM ET Dec 12, 2025
  

  CellaVision appoints Monica Jönsson as CFO with immediate effect (SEK 154.80, +1.00)

• 01:21 AM ET Dec 08, 2025
  

  CellaVision receives CE marking according to IVDR Class C for CellaVision Bone Marrow Aspirate Application (SEK 156.20, 0.00)

• 06:38 AM ET Nov 06, 2025
  

  Transcript Intelligence: CellaVision Q3 Earnings Guidance (SEK157.20, -18.80)